Jun 2026 (Q2 FY26) — Jul 29, 2026
IDEX Corporation Q2 FY26 — Strong Orders and Raised Full-Year Outlook
Read the full callIDEX (IEX) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
IDEX earnings: last reported Wed, 29 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 921 | +6.4% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 21.7 | 0.0 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 143 | +9.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$236.42 −0.92% · −$2.2
Performance +73.7% 1Y
1Y: $136.09 on 14 Oct 2025 → $236.42. High $238.62 (14 Oct 2026), low $114.75 (30 Mar 2026).
- Previous close
- $238.62
- 52-week range
- $114.75 – $238.62
- One year
- +74.66%
Overview
- Symbol
- IEX
- Exchange
- US
- Currency
- USD
Call summaries
Mar 2026 (Q1 FY26) — Apr 29, 2026
IDEX Q1 FY26 — Strong Organic Growth and Raised Full-Year Outlook
Read the full callEvery analysed call
IDEX earnings calls (IEX)
Financials
What the filings say
Net profit, year on year: +9% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 798 | 863 | 814 | 865 | 879 | 899 | 887 | 921 |
| Operating profit | 168 | 165 | 142 | 188 | 186 | 184 | 172 | 200 |
| Operating margin | 21.1% | 19.2% | 17.4% | 21.7% | 21.1% | 20.4% | 19.4% | 21.7% |
| Interest | 10 | — | — | — | — | — | — | — |
| Profit before tax | 154 | 151 | 125 | 170 | 171 | 168 | 157 | 186 |
| Tax rate | 23.0% | 18.5% | 23.4% | 22.8% | 25.1% | 23.5% | 23.6% | 22.9% |
| Net profit | 119 | 123 | 96 | 132 | 128 | 128 | 120 | 143 |
| EPS ($ per share) | 1.57 | — | 1.26 | 1.74 | 1.70 | — | 1.61 | 1.94 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | 2,342 | 2,615 | 2,842 | 3,127 | 3,532 | 3,934 | 4,230 | 4,500 |
| Total liabilities | 1,479 | 1,551 | 1,874 | 2,114 | 2,472 | 2,324 | 2,951 | 2,901 |
| Fixed assets | 281 | 280 | 298 | 327 | 382 | 430 | 460 | 468 |
| Total assets | 3,474 | 3,814 | 4,414 | 4,917 | 5,512 | 5,865 | 6,745 | 6,927 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 479 | 528 | 569 | 565 | 557 | 717 | 668 | 680 |
| Cash from investing | -81 | -137 | -173 | -698 | -917 | -284 | -1,006 | -138 |
| Cash from financing | -290 | -228 | -43 | -9 | -38 | -345 | 466 | -633 |
| Net cash flow | 90 | 166 | 393 | -170 | -425 | 104 | 105 | -53 |
| Capital expenditure | -56 | -51 | -52 | -73 | -68 | -90 | -65 | -64 |
| Free cash flow | 423 | 477 | 518 | 493 | 489 | 627 | 603 | 617 |
IEX revenue by segment
Health and Science Technologies grew from 39% to 45% of revenue over the last two years.
| Segment | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Health and Science Technologies | 39% | 43% | 42% | 42% | 43% | 45% | 45% | 45% | +13.8% |
| Fluid and Metering Technologies | 38% | 35% | 36% | 36% | 36% | 34% | 34% | 34% | +2.0% |
| Fire and Safety Diversified Products | 24% | 22% | 23% | 22% | 21% | 21% | 21% | 21% | -0.6% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Revenue by region
Q2 FY2026 · share of revenue
- US 51% ↑ 1 pt
- Europe 24%
- Asia 17%
- Other Geographical Areas 5%
- North America Excluding United States 3% ↓ 1 pt
As IEX cuts its regions in its filings; they can nest, so they need not add to 100%.
Insider filings
28 filings between Nov 5, 2025 and Sep 16, 2026.
Open market
decisions to buy or sellPurchases
$101.6K
1 purchase by 1 insider
Sales
$3.40M
3 sales by 2 insiders
Compensation
not trading decisions- 16
- Award — granted as compensation
- 2
- Option exercise — converted options into shares
- 6
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| ASHLEMAN ERIC D | — | $3.31M | May 11, 2026 |
| Christenson Carl R | $101.6K | — | Nov 5, 2025 |
| Anderson Lisa M | — | $91.9K | Aug 12, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 16, 2026 | Simmons William L. Group Executive, FMT & FSDP | Tax withheld | 218 | $48.6K |
| Sep 16, 2026 | Tereso Tara M. Group Executive, HST | Tax withheld | 290 | $64.6K |
| Sep 11, 2026 | Tereso Tara M. Group Executive, HST | Tax withheld | 138 | $30.6K |
| Aug 29, 2026 | Lausas Allison S VP, Chief Accounting Officer | Tax withheld | 645 | $148.5K |
| Aug 12, 2026 | Anderson Lisa M SVP, GC, CAO & Corp Sec | Sale | 385 | $91.9K |
| Aug 12, 2026 | Anderson Lisa M SVP, GC, CAO & Corp Sec | Option exercise | 385 | $35.9K |
| May 11, 2026 | ASHLEMAN ERIC D CEO and President | Sale | 4,915 | $1.06M |
| May 11, 2026 | ASHLEMAN ERIC D CEO and President | Option exercise | 15,385 | $1.43M |
| May 11, 2026 | ASHLEMAN ERIC D CEO and President | Sale | 10,470 | $2.25M |
| May 6, 2026 | Disher Stephanie Director | Award | 805 | $0 |
| May 6, 2026 | Glastra Matthijs Director | Award | 805 | $0 |
| May 6, 2026 | Gunter Lakecia N Director | Award | 805 | $0 |
| May 6, 2026 | Helmkamp Katrina L Director | Award | 1,035 | $0 |
| May 6, 2026 | Watts Stanfield Paris Director | Award | 805 | $0 |
| May 6, 2026 | Beck Mark A Director | Award | 805 | $0 |
| May 6, 2026 | Quiroz Alejandro Director | Award | 805 | $0 |
| May 6, 2026 | Christenson Carl R Director | Award | 805 | $0 |
| May 6, 2026 | BUTHMAN MARK A Director | Award | 805 | $0 |
| Feb 23, 2026 | Tereso Tara M. Group Executive, HST | Tax withheld | 154 | $32.0K |
| Feb 22, 2026 | ASHLEMAN ERIC D CEO and President | Award | 9,040 | $0 |
| Feb 20, 2026 | Lausas Allison S VP, Chief Accounting Officer | Tax withheld | 179 | $37.2K |
| Feb 19, 2026 | Lausas Allison S VP, Chief Accounting Officer | Award | 275 | $0 |
| Feb 19, 2026 | Simmons William L. Group Executive, FMT & FSDP | Award | 1,055 | $0 |
| Feb 19, 2026 | Tereso Tara M. Group Executive, HST | Award | 1,055 | $0 |
| Feb 19, 2026 | Anderson Lisa M SVP, GC, CAO & Corp Sec | Award | 1,205 | $0 |
| Feb 19, 2026 | Gillen Sean M. SVP, Chief Financial Officer | Award | 2,410 | $0 |
| Jan 5, 2026 | Gillen Sean M. SVP, Chief Financial Officer | Award | 16,595 | $0 |
| Nov 5, 2025 | Christenson Carl R Director | Purchase | 600 | $101.6K |
| Aug 7, 2025 | Helmkamp Katrina L Director | Purchase | 2,500 | $399.0K |
| Jun 5, 2025 | Mahendra Akhil Interim CFO | Sale | 250 | $45.2K |
| May 30, 2025 | Mahendra Akhil Interim CFO | Award | 2,765 | $0 |
| May 8, 2025 | Watts Stanfield Paris Director | Award | 895 | $0 |
| May 8, 2025 | Beck Mark A Director | Award | 895 | $0 |
| May 8, 2025 | BUTHMAN MARK A Director | Award | 895 | $0 |
| May 8, 2025 | Christenson Carl R Director | Award | 895 | $0 |
| May 8, 2025 | Disher Stephanie Director | Award | 895 | $0 |
| May 8, 2025 | Glastra Matthijs Director | Award | 895 | $0 |
| May 8, 2025 | Gunter Lakecia N Director | Award | 895 | $0 |
| May 8, 2025 | Helmkamp Katrina L Director | Award | 1,165 | $0 |
| May 8, 2025 | Quiroz Alejandro Director | Award | 895 | $0 |
| Feb 21, 2025 | Glastra Matthijs Director | Award | 180 | $0 |
| Feb 21, 2025 | Disher Stephanie Director | Award | 180 | $0 |
| Feb 20, 2025 | Lausas Allison S VP, Chief Accounting Officer | Award | 775 | $0 |
| Feb 20, 2025 | Unnikrishnan Roopa SVP, Strategy&Corp Development | Award | 830 | $0 |
| Feb 20, 2025 | Flores Melissa S SVP, CHRO | Award | 865 | $0 |
| Feb 20, 2025 | Anderson Lisa M SVP, General Counsel &Corp Sec | Award | 1,025 | $0 |
| Feb 20, 2025 | ASHLEMAN ERIC D CEO and President | Award | 7,760 | $0 |
| Feb 20, 2025 | Khandelwal Abhishek SVP, Chief Financial Officer | Award | 1,725 | $0 |
| Feb 11, 2025 | Unnikrishnan Roopa SVP, Strategy&Corp Development | Award | 657 | $129.1K |
| Feb 11, 2025 | Unnikrishnan Roopa SVP, Strategy&Corp Development | Tax withheld | 369 | $72.5K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for IDEX CORP /DE/
Free account. Everything above stays public.
Write why you follow IDEX CORP /DE/ and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading